These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 1974317)

  • 1. [The central nervous system and inflammation: the role of opioid peptides].
    Mazzone A; Ricevuti G; Fioravanti A; Pasotti D; Vitto AR; Mirto L; Vignali C; Avato F; Notario A
    Medicina (Firenze); 1990; 10(1):23-5. PubMed ID: 1974317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The nervous system and the immune system: the role of morphine and opioid peptides in the function of neutrophilic granulocytes].
    Pasotti D; Mazzone A; Ricevuti G
    Minerva Med; 1992; 83(7-8):433-8. PubMed ID: 1326093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of opioid peptides on peripheral blood granulocytes].
    Pasotti D; Mazzone A; Lecchini S; Frigo GM; Ricevuti G
    Riv Eur Sci Med Farmacol; 1993; 15(2):71-81. PubMed ID: 7909619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide opioids and morphine effects on inflammatory process.
    Mazzone A; Ricevuti G; Pasotti D; Fioravanti A; Marcoli M; Lecchini S; Notario A; Frigo GM
    Inflammation; 1990 Dec; 14(6):717-26. PubMed ID: 1982531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid-induced modification of granulocyte function.
    Marcoli M; Ricevuti G; Mazzone A; Bekkering M; Lecchini S; Frigo GM
    Int J Immunopharmacol; 1988; 10(4):425-33. PubMed ID: 2844685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effects of dynorphins through nonopioid intracellular mechanisms.
    Tan-No K; Cebers G; Yakovleva T; Hoon Goh B; Gileva I; Reznikov K; Aguilar-Santelises M; Hauser KF; Terenius L; Bakalkin G
    Exp Cell Res; 2001 Sep; 269(1):54-63. PubMed ID: 11525639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro effects of morphine and opioid peptides on granulocyte migration].
    Pasotti D; Marcoli M; Mazzone A
    Medicina (Firenze); 1988; 8(1):53-5. PubMed ID: 2906399
    [No Abstract]   [Full Text] [Related]  

  • 8. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
    Huidobro-Toro JP; Zhu YX; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):293-303. PubMed ID: 6141281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro effects of morphine and opioid peptides on neutrophil granulocyte aggregation and ATP release].
    Pasotti D; Mazzone A; Ricevuti G
    Recenti Prog Med; 1989 Oct; 80(10):557-60. PubMed ID: 2602639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [D-Pro10]-dynorphin(1-11) is a kappa-selective opioid analgesic in mice.
    Gairin JE; Gout R; Meunier JC; Cros J
    J Pharmacol Exp Ther; 1988 Jun; 245(3):995-1001. PubMed ID: 2898527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulators of pain in the spinal cord.
    Jen MF; Lu CH; Huang L; Han JS
    NIDA Res Monogr; 1986; 75():457-60. PubMed ID: 2893278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynorphin A (1-13): in vivo opioid antagonist actions and non-opioid anticonvulsant effects in the rat flurothyl test.
    Tortella FC; Holaday JW
    NIDA Res Monogr; 1986; 75():539-42. PubMed ID: 2893282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of endogenous opioid peptides on TRH release from rat stomach in vitro.
    Mitsuma T; Hirooka Y; Nakada K; Nomura A; Nogimori T
    Endocrinol Exp; 1989 Mar; 23(1):11-6. PubMed ID: 2565806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of some nonopioid actions of dynorphin.
    Walker JM; Moises HC; Friederich MW
    Prog Clin Biol Res; 1985; 192():309-12. PubMed ID: 2867551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Opiate receptors, endorphins and their antagonists].
    Papin AA; Karelin AA
    Anesteziol Reanimatol; 1984; (3):52-61. PubMed ID: 6148029
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensitivity to morphine-evoked bradycardia in rats is modified by dynorphin (1-13), Leu- and Met-enkephalin.
    Kiang JG; Wei ET
    J Pharmacol Exp Ther; 1984 May; 229(2):469-73. PubMed ID: 6716269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of N-ethylmaleimide treatment on naloxone binding in frog brain membranes.
    Zawilska J; Lajtha A; Borsodi A
    Acta Biochim Biophys Hung; 1989; 24(1-2):33-9. PubMed ID: 2575315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some aspects of physiology and pharmacology of endogenous opioid peptides.
    Przewłocki R
    Pol J Pharmacol Pharm; 1984; 36(2-3):137-58. PubMed ID: 6147828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.